OpenAI sued over claims ChatGPT advised woman to cut seizure drugs

The parents of a 31-year-old Amazon software engineer with epilepsy have sued OpenAI, alleging that ChatGPT encouraged their daughter to reduce her seizure medication without medical supervision and hide the changes from her doctors before she died in February. The lawsuit, filed by Qun Wan and Meiqin Xu on Tuesday, centres on their daughter, Bowen Wan, who used OpenAI’s GPT-4o model while managing epilepsy, according to a report by The New York Times, which reviewed more than 270,000 messages exchanged between Wan and the chatbot. The case alleges that the chatbot helped Wan develop a plan to taper off lamotrigine, an anti-seizure medication, while reassuring her about symptoms that resembled previous seizures.